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We have synthesised [3H]tetrahydrocerulenin, a radio-labelled derivative of cerulenin, an antibiotic from 
Cephalosporium caerulens which specifically inhibits the condensing enzyme of fatty acid synthases and 
polyketide synthases from various sources. [3H]Tetrahydrocerulenin binds to fatty acid synthase from pig 
liver with the same specificity as cerulenin. We have also used [3H]tetrahydrocerulenin to monitor 
condensing enzyme activity in cell-free extracts of the erythromycin-producing organism Streptomyces 
erythreus. 
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1. INTRODUCTION 
Cerulenin [(2R)(3S)-2,3-epoxy-Coxo-7,1O-dode- 
cadienoylamide] (structure lA), an antibiotic 
isolated from Cephalosporium caerulens [ 11, is a 
potent inhibitor of fatty acid synthase systems 
from various micro-organisms and animal tissues 
[2-41. The antibiotic specifically and irreversibly 
Structure 1 
Structure of cerulenin (1A) and of 
[3H]tetrahydrocerulenin (1B) showing the anticipated 
distribution of tritium label 
‘H 3H 
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blocks the activity of &ketoacyl thioester synthase 
(condensing enzyme) [3,4], and it has been propos- 
ed that cerulenin becomes covalently bound to the 
‘peripheral’ cysteine residue at the active site of the 
condensing enzyme [5]. Cerulenin has also been 
found to inhibit the biosynthesis of various 
polyketide-derived natural products such as 
6-methylsalicylic acid [6] and the macrolide an- 
tibiotics leucomycin [7] and candicidin [8], sug- 
gesting that the condensing enzyme in polyketide 
biosynthesis resembles the analogous component 
of fatty acid synthase. 
This report describes the synthesis of 
[‘Hltetrahydrocerulenin (lb) and its use for 
specific labelling of fatty acid synthase. We also 
report the use of the reagent for detection of fatty 
acid synthase and related enzymes in bacterial 
extracts. 
2. MATERIALS AND METHODS 
CoA esters were purchased from Sigma 
Chemicals (St Louis MO). Cerulenin was supplied 
by C.P. Labs. (Bishop’s Stortford, Herts). 
Tritiated tetrahydrocerulenin (about 45 Ci/mmol) 
was prepared by catalytic reduction of cerulenin 
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with carrier-free tritium gas over PtO2, essentially precipitated with 5 vol. acetone. The pellets were 
as in 191. This was performed by the tritium labell- washed twice with acetone and then dissolved in 
ing service of Amersham Internation~ (Amersh~ gel sample buffer [13] and heated at 100°C for 
Bucks). Portions of the product were purified 2 min before applying to the gel. After elec- 
before use by preparative TLC on silica plates trophoresis, overnight at 50 V, gels were stained 
(Merck) eluted with chloroform-methanol (25 : 1, 
v/v). In this system [3H]tetrahydrocerulenin 
with methanol-acetic acid-water (5 : 1: 5, by vol.) 
containing 0.1% Coomassie brilliant blue for 
migrated with an RF of 0.35. The presumed labell- 30 min at 6O”C, and subsequently destained in the 
ing pattern is shown in structure 1B. same solvent mixture at room temperature. 
2.1. Purification of fatty acid synthase 2.5. Fluorography 
Fatty acid synthase was purified from pig liver 
by a published procedure [lo], except hat gel- 
filtration on Bio-gel AlSm (Bio-Rad) replaced 
fractionation on a sucrose density gradient. The 
final specific activity (overall complex) was 
34 nkat/mg. 
The destained gels were photographed, and 
prepared for fluorography as in [ 141. The dried 
gels were exposed at - 70°C to pre-flashed X-ray 
film (Fuji RX) for 7 days. 
3. RESULTS AND DISCUSSION 
2.2. Preparation of extracts of Streptomyces 
erythreus 
Strepto~yces erythreus CA340 (Abbott), a mu- 
tant strain that overproduces erythromycin, was 
grown vegetatively as in (1 11. For production of 
antibiotic, mycelium was transferred to a sucrose- 
containing medium [12]. Cells were washed, 
resuspended (2 ml/g wet wt) in 50 mM Tris-HCI 
(PH 7.4), cont~i~ng 2 mM EDTA, 1 mM 
dithiothreitol, and glycerol (lo%, v/v), and 
disrupted by two passes through a French pressure 
cell operated at maximum pressure. Cell debris was 
removed by centrifugation (I2000 x g, 10 min) 
and streptomycin sulphate (final cont. I%, w/v) 
was added to precipitate nucleic acids. The mixture 
was re-centrifuged (27000 x g, 20 min) and the 
supernatant was used for the labelling experiments 
described below. 
Incubation of purified fatty acid synthase from 
pig liver with [3H]tetrahydrocerulenin resulted in 
apparently covalent attachment of the tritiated 
Iigand to the protein. This labelling was 
To 50 pg purified fatty acid synthase (or 200 pg 
protein from S. erythreus extracts) in 0.2 ml 
50 mM Tris-HCl (pH 7.4) at 2O”C, 
[3H]tetrahydrocerulenin (fi al cont. 30 /IM) was 
added, followed 10 min later by excess unlabelled 
cerulenin (0.2 mM). The cerulenin ‘chase’ was 
found to be essential to minimise non-specific 
iabelling. 
2.4. Gel electrophoresis 
SDS-polyacrylamide gel electrophoresis was 
performed in slab gels [ 131. Protein samples were 
Fig. I. 12.5% SDS-polyacrylamide gel electrophoresis 
of pig liver fatty acid synthase treated with 
13H]tetrahydroce~lenin. Proteins were detected either 
(A) with Coomassie brilliant blue or (B) by 
fluorography: (1) fatty acid synthase (40 ,ug); (2) fatty 
acid synthase (10 pg) pre-incubated with acetyl-CoA 
(1 mM); (3) fatty acid synthase (2Occg) pre-incubated 
with cerulenin (0.5 mM). 
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demonstrated in fluorograms of gels containing 
fatty acid synthase, after electrophoresis in the 
presence of 0.1% SDS (fig. 1). The labelling of fat- 
ty acid synthase was abolished either in the 
presence of cerulenin (which binds very much more 
tightly to fatty acid synthase than does 
tetrahydrocerulenin [3]) or in the presence of 
acetyl-CoA, which is known to compete with 
cerulenin for the cysteine sidechain in the condens- 
ing enzyme [5]. NADPH and malonyl-CoA gave 
very little protection against labelling by 
[3H]tetrahydrocerulenin ( ot shown) which is also 
consistent with the idea that the tritiated ligand 
and cerulenin bind to the same unique site in fatty 
acid synthase [5]. 
Fatty acid synthase from various animal sources 
has been shown to consist of a dimer of identical 
subunits, each of MI 220000-250000 [15-171. The 
7 individual enzyme activities of the multienzyme 
complex are therefore properties of a single type of 
polypeptide chain. The availability of 
[3H]tetrahydrocerulenin, a radio-labelled active 
site-directed inhibitor of the condensing enzyme, 
should allow us to undertake structural studies on 
this enzyme component of the multifunctional 
polypeptide. 
We have also used [3H]tetrahydrocerulenin i at- 
tempts to detect fatty acid synthase-like nzymes in 
cell-free extracts of the erythromycin-producing 
organism Streptomyces erythreus. The core 
aglycone of erythromycin is constructed from 1 
molecule of propionyl-CoA and 6 molecules of 
methylmalonyl-CoA, in a process analogous to 
fatty acid biosynthesis [ 181. Unfortunately, very 
little is known about the enzyme responsible, 
erythronolide synthase. The analogy between this 
enzyme and fatty acid synthase is strengthened by 
our finding (unpublished) that cerulenin, when 
added to resting cells of S. erythreus in the 
antibiotic-producing phase at the end of exponen- 
tial growth, totally inhibits production of 
erythromycin. 
Only one polypeptide (Mr -70000) is significant- 
ly labelled by [‘Hltetrahydrocerulenin in cell-free 
extracts of exponentially-growing S. erythreus (see 
fig.2). When extracts were examined from cells 
early in the antibiotic-producing phase, additional 
bands were detected after fluorography (fig.2). In- 
terestingly, the major new band of radioactivity 
(Mr 35 000) has the same mobility as the fi-ketoacyl 
Fig.2. 12.5% SDS-polyacrylamide gel electrophoresis 
of S. erythreus extracts treated with [3H]tetrahydrocer- 
ulenin. Proteins were detected either (A) with Coomassie 
brilliant blue or (B) by fluorography: (1) extract from 
exponentially-growing cells; (2) extract from differen- 
tiated cells (antibiotic-producing phase); (3) extract from 
differentiated cells, pre-incubated with propionyl-CoA 
(1 mM). 
ACP synthase I (condensing enzyme) from E. coli 
[ 19,201. Labelling of the MI 35000 polypeptide was 
greatly reduced in the presence of propionyl-CoA. 
Cerulenin and acetyl-CoA were also effective in 
preventing labelling of the polypeptide (not 
shown). Further experiments will be required to 
clarify the relationship between this apparent con- 
densing enzyme activity present in differentiated S. 
erythreus, and macrolide antibiotic synthesis 
which occurs specifically at this phase of growth. 
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